Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesTopiramate-Induced Intractable Cough During Migraine Prophylaxis
Headache: The Journal of Head and Face Pain, 09/16/09
Maggioni F et al. – Topiramate is a highly effective drug in migraine prophylaxis and is considered a first–line treatment. The evidence for the efficacy of topiramate is based upon the results of several large, randomized, double–blind, placebo–controlled trials. Adverse events (AEs) are common and require discontinuation of the treatment in about 20–25% of patients, but they are rarely severe. There are reviews regarding topiramate–related AEs representing a large number of patients treated in controlled trials. The most common AEs are weight loss, dizziness, somnolence, abnormal thinking, fatigue, ataxia, confusion, paresthesias, impaired concentration, nervousness, amnesia, and language difficulties. The development of cough has never been reported as an AE during topiramate prophylaxis for migraine. The authors present 3 cases in which the prophylactic treatment for migraine with topiramate was discontinued due to the onset of primary intractable coughing.
Today in Neurology/Neurosurgery...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Stroke treatment with alteplase given 3·0—4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
The Lancet Neurology, 11/17/09
Safety and Efficacy of IV-TPA for Ischaemic Stroke in Clinical Practice - A Bayesian Analysis
Cerebrovascular Diseases, 10/30/09
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
Article Search
Sponsor